{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:23:42Z","timestamp":1782815022206,"version":"3.54.5"},"reference-count":24,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> The results of two longitudinal studies of growth rates of vestibular schwannomas (VSs) in patients with neurofibromatosis Type 2 (NF2) differ as to whether VS growth rates decrease or increase with increasing patient age. The authors undertook this study to assess the relationship between VS growth rates and patient age and type of constitutional <jats:italic>NF2<\/jats:italic> mutation; they also examined variability in VS growth rates among multiple patients in families with NF2.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> Gadolinium-enhanced magnetic resonance images obtained in 18 patients with inherited NF2 from 11 unrelated families were retrospectively analyzed. The patients had been observed for a median of 4 years. Volumes of the VSs were measured using a two-component box model (intrameatal and extrameatal parts measured separately). Single-strand conformation polymorphism analysis and Southern blot analysis were used to identify constitutional <jats:italic>NF2<\/jats:italic> mutations. Growth rates of the VSs were highly variable, but tended to decrease with increasing patient age both at onset of signs or symptoms of NF2 (r<jats:sup>2<\/jats:sup> = 0.35, p = 0.026) and at diagnosis (r<jats:sup>2<\/jats:sup> = 0.33, p = 0.012). The VS growth rates did not vary significantly with the type of constitutional <jats:italic>NF2<\/jats:italic> mutation or the number of non-VS cerebral or spinal tumors. The VS growth rates were highly variable within families and did not correspond to clinical indices of NF2 disease severity, such as patient age at symptom onset and the number of non-VS cerebral and spinal tumors.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> The growth rates of VSs in patients with NF2 are highly variable, but tend to decrease with increasing patient age. Clinical treatment of multiple patients in families with NF2 cannot be based on the expectations of similar VS growth rates, even when other clinical aspects of disease severity are similar.<\/jats:p>","DOI":"10.3171\/jns.2002.96.2.0217","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:47:54Z","timestamp":1242236874000},"page":"217-222","source":"Crossref","is-referenced-by-count":90,"title":["Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2"],"prefix":"10.3171","volume":"96","author":[{"given":"Michael E.","family":"Baser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erini V.","family":"Makariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilys M.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00005537-199606000-00007","article-title":"Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2.","volume":"106","author":"Abaza","year":"1996"},{"key":"b2","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00005072-199511000-00004","article-title":"Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling.","volume":"54","author":"Antinheimo","year":"1995"},{"key":"b3","series-title":"Am J Med Genet","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q","article-title":"Phenotypic variability in monozygotic twins with neurofibromatosis 2.","volume":"64","author":"Baser","year":"1996"},{"key":"b4","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1227\/00006123-199105000-00002","article-title":"Conservative treatment of patients with acoustic tumors.","volume":"28","author":"Bederson","year":"1991"},{"key":"b5","series-title":"Otolaryngol Head Neck Surg","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0194-5998(95)70138-9","article-title":"Acoustic neuroma (vestibular schwannoma): growth and consequences of the wait-and-see policy.","volume":"113","author":"Charabi","year":"1995"},{"key":"b6","series-title":"Q J Med","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis.","volume":"84","author":"Evans","year":"1992"},{"key":"b7","series-title":"J Med Genet","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.","volume":"35","author":"Evans","year":"1998"},{"key":"b8","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s002340050475","article-title":"The size of acoustic neuromas: CT and MRI.","volume":"39","author":"Fiirgaard","year":"1997"},{"key":"b9","series-title":"Hum Genet","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004390050255","article-title":"Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.","volume":"98","author":"Kluwe","year":"1996"},{"key":"b10","series-title":"Am J Med Genet","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.0.CO;2-L","article-title":"Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.","volume":"77","author":"Kluwe","year":"1998"},{"key":"b11","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00548193","article-title":"Volume growth rate of acoustic neurinomas.","volume":"28","author":"Laasonen","year":"1986"},{"key":"b12","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/00005537-200011000-00015","article-title":"Tumor growth and audiometric change in vestibular schwannomas managed conservatively.","volume":"110","author":"Massick","year":"2000"},{"key":"b13","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","article-title":"Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.","volume":"96","author":"Mautner","year":"2002"},{"key":"b14","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00006123-199605000-00004","article-title":"The neuroimaging and clinical spectrum of neurofibromatosis 2.","volume":"38","author":"Mautner","year":"1996"},{"key":"b15","series-title":"AJR","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2214\/ajr.165.4.7676998","article-title":"Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety.","volume":"165","author":"Mautner","year":"1995"},{"key":"b16","series-title":"Otolaryngol Clin North Am","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0030-6665(20)30969-5","article-title":"Conservative management of acoustic neuromas.","volume":"25","author":"Nedzelski","year":"1992"},{"key":"b17","series-title":"Am J Med Genet","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.","volume":"52","author":"Parry","year":"1994"},{"key":"b18","series-title":"Am J Hum Genet","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.","volume":"59","author":"Parry","year":"1996"},{"key":"b19","series-title":"Nature","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993"},{"key":"b20","series-title":"Am J Hum Genet","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.","volume":"59","author":"Ruttledge","year":"1996"},{"key":"b21","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00005072-199303000-00002","article-title":"Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases.","volume":"52","author":"Sobel","year":"1993"},{"key":"b22","series-title":"Human Molecular Genetics.","first-page":"589","author":"Strachan","year":"1996"},{"key":"b23","series-title":"Laryngoscope","first-page":"1115","article-title":"The natural history of untreated acoustic neuromas.","volume":"104","author":"Strasnick","year":"1994"},{"key":"b24","series-title":"Cell","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.","volume":"72","author":"Trofatter","year":"1993"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/2\/article-p217.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/2\/article-p217.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/2\/article-p217.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:50:01Z","timestamp":1679867401000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/2\/article-p217.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns.2002.96.2.0217","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}